Recurring structural chromosome abnormalities in peripheral blood lymphocytes of patients with mycosis fungoides/sezary syndrome

Blood

Volumn 89, Issue 9, 1997, Pages 3371-3377

  Thangavelu, Maya ^a,b   Finn, William G ^a   Yelavarthi, Krishna K ^a   Roenigk Jr , Henry H ^a   Samuelson, Ellen ^a   Peterson, LoAnn ^a   Kuzel, Timothy M ^a   Rosen, Steven T ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 7;

ARTICLE; CHROMOSOME 1P; CHROMOSOME STRUCTURE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE; MALE; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; SEX CHROMOSOMAL INHERITANCE; SEZARY SYNDROME; STRUCTURE ANALYSIS;

EID: 0030904865     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.9.3371     Document Type: Article

References (49)

1. Crossen PE, Mellor JEL, Finley AG, Ravich RB, Vincent PC, Gunz FW: The Sézary syndrome. Cytogenetic studies and identification of the Sézary cell as an abnormal lymphocyte. Am J Med 50:24, 1971
2. Erkman-Balis B, Rappaport H: Cytogenetic studies in mycosis fungoides. Cancer 34:626, 1974
3. Whang-Peng J, Lutzner M, Edelson R, Knutsen T: Cytogenetic studies and clinical implications in patients with Sézary syndrome. Cancer 38:861, 1976
4. Goh K-O, Reddy MM, Joishy SK: Chromosomes and B and T cells in mycosis fungoides. Am J Med Sci 276:197, 1978
5. Van Vloten WA, Pet EA, Geraedts JPM: Chromosome studies in mycosis fungoides. Br J Dermatol 102:507, 1980
6. Shah-Reddy I, Mayeda K, Mirchandani I, Koppitch FC: Sézary syndrome with a 14:14 (q12;q31) translocation. Cancer 49:75, 1982
7. Mecucci C, Michaux J, Tricot G, Louwagie A, van Den Berghe H: Rearrangements of the short arm of chromosome no. 6 in T-cell lymphomas. Leuk Res 9:1139, 1985
8. Schmidt M, Stolzmann WM, Neumann E: Cytogenetic findings in a case of Sézary syndrome. Cancer Genet Cytogenet 16:117, 1985
9. Nowell PC, Vonderheid EC, Besa E, Hoxie JA, Moreau L, Finan JB: The most common chromosome change in 86 chronic B cell or T cell tumors: A 14q32 translocation. Cancer Genet Cytogenet 19:219, 1986
10. Berger R, Bernheim A: Cytogenetic studies of Sézary cells. Cancer Genet Cytogenet 27:79, 1987
11. Mecucci C, Louwagie A, Thomas J, Boogaerts M, van Den Berghe H: Cytogenetic studies in T-cell malignancies. Cancer Genet Cytogenet 30:63, 1988
12. Berrebi A, Virst EJ, Chemke J: Chromosomal abnormalities in Sézary's lymphoma. Eur J Hematol 43:85, 1989
13. Santos M, Benitez J, Rivas C: Possible correlation between a specific alteration t(7;14) and the rearrangement of TCR observed in a Sézary syndrome. Cancer Genet Cytogenet 46:281, 1990
14. Sole F, Tarrida N, Coll MD, Caballin MR, De Miguel A, Woessner S, Egozcue J: Cytogenetic study of a patient with the Sézary syndrome. Cancer Genet Cytogenet 44:193, 1990
15. Sole F, Woessner S, Vallespi T, Losada AP, Florensa L, Irriguible D, Vila J, Sans-Sabrafen J: Cytogenetic studies in five patients with Sézary syndrome. Cancer Genet Cytogenet 75:130, 1994
16. Bosman FT, van Vloten WA: Sézary syndrome: A Cytogenetic, cytophotometric and autoradiographic study. J Pathol 118:49, 1976
17. Liang JC, Gaulden ME, Herndon JH: Chromosome markers and evidence for clone formation in lymphocytes of a patient with Sézary syndrome. Cancer Res 40:3426, 1980
18. Nowell P, Daniele R, Rowlands D Jr, Finan J: Cytogenetics of chronic B-cell and T-cell leukemias. Cancer Genet Cytogenet 1:273, 1980
19. Zech L, Godal T, Hammarstrom L, Mellstedt H, Smith CIE, Totterman T, Went M: Specific chromosome markers involved with chronic T lymphocyte tumors. Cancer Genet Cytogenet 21:67, 1986
20. D'Allessandro E. Paterlini P, Lo Re ML, Di Cola M, Ligas C, Quaglino D, Del Porto G: Cytogenetic follow-up in a case of Sézary syndrome. Cancer Genet Cytogenet 45:231, 1990
21. Whang-Peng J, Bunn P, Knutsen T, Schechter GP, Gazdar AF, Matthews MJ, Minna JD: Cytogenetic abnormalities in patients with cutaneous T-cell lymphomas. Cancer Treat Rep 63:575, 1979
22. Whang-Peng J, Bunn PA, Knutsen T, Matthews MJ, Schechter G, Minna JD: Clinical implications of Cytogenetic studies in cutaneous T-cell lymphoma (CTCL). Cancer 50:1539, 1982
23. Edelson RL, Berger CL, Raafat J, Warburton D: Karyotype studies of cutaneous T cell lymphoma. Evidence for clonal origin. J Invest Dermatol 73:548, 1979
24. Nowell PC, Finan JB, Vonderheid EC: Clonal characteristics of cutaneous T cell lymphomas: Cytogenetic evidence from blood, lymph nodes and skin. J Invest Dermatol 78:69, 1982
25. Bunn PA, Whang-Peng J, Carney DN, Schlam ML, Knutsen T, Gazdar AF: DNA content analysis by flow cytometry and cytogenetic analysis in mycosis fungoides and Sézary syndrome. J Clin Invest 65:1440, 1980
26. Foss FM, Koc Y, Stetler-Stevenson MA, Nguyen DT, O'Brien MC, Turner R, Sausville EA: Costimulation of cutaneous T-cell lymphoma cells by interleukin-7 and interleukin-2: Potential autocrine or paracrine effectors in the Sézary syndrome. J of Clin Oncol 12:326, 1994
27. Bunn PA, Lamberg SI: Report of the committee on staging and classification of cutaneous t-cell lymphomas. Cancer Treat Rep 63:725, 1979
28. ISCN, Mitelman F (ed): Guidelines for Cancer Cytogenetics. Supplement to An International System for Human Cytogenetic Nomenclature. Basel, Switzerland, Karger, 1991
29. 28a. Kaplan E, Meier P: Nonparametric estimation from incomplete observations J. Am Stat Assoc 53:457, 1958
30. Bieche I, Champeme MH, Matifas F, Cropp CS, Callahan R, Lidereau R: Two distinct regions involved in 1p deletion in human primary breast cancer. Cancer Res 53:1990, 1993
31. Leister I, Weith A, Bruderlein S, Czieplich C, Kangwanpong D. Schlag P, Schwab M: Human colorectal cancer: High frequency of deletions at chromosome 1p35. Cancer Res 50:7232, 1990
32. Simon D. Knowles BB, Weith A: Abnormalities of chromosome 1 and loss of heterozygosity on 1p in primary hepatomas. Oncogene 6:765, 1991
33. Dracopoli NC, Harnett P, Bale SJ, Stanger BZ, Tucker MA, Housman DE, Kefford RF: Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression. Proc Natl Acad Sci USA 86:4614, 1989
34. Jenkins RB, Kimmel DW, Moertel CA, Schultz CG, Scheithauer BW, Kelly PJ, Dewald GW: A cytogenetic study of 53 human gliomas. Cancer Genet Cytogenet 39:253, 1989
35. Flejter WL, Li FP, Antman KH, Testa JR: Recurring loss involving chromosomes 1, 3 and 22 in malignant mesothelioma: Possible sites of tumor suppressor genes. Genes Chromosomes Cancer 1:148, 1989
36. Schleiermacher G, Peter M, Michon J, Hugot J-P, Vielh P, Zucker J-M, Magdelenat H, Thomas G, Delattre O: Two distinct deleted regions on the short arm of chromosome 1 in neuroblastoma. Genes Chromosomes Cancer 10:275, 1994
37. Sano T, Tsujino T, Yoshida K, Nakayama H, Haruma K, Ito H, Nakamura Y, Kajiyama G, Tahara E: Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas. Cancer Res 51:2926, 1991
38. Tstsumi M, Yokota J, Kakizoe T, Koiso K, Sugimura T, Terada M: Loss of heterozygosity on chromosome 1p and 11p in sporadic pheochromocytoma. J Natl Cancer Inst 81:367, 1989
39. Mathew CGP. Smith BA, Thorpe K, Wong Z, Royle NJ, Jeffreys AJ, Ponder BAJ: Deletion of genes on chromosome 1 in endocrine neoplasia. Nature 328:524, 1987
40. Mitelman F, Kaneko Y, Trent J: Report of the committee on chromosome changes in neoplasia. Cytogenet Cell Genet 58:1053, 1991
41. Janssen JWG, Ludwig W, Sterry W, Bartram CR: SIL-TALI deletion in T-cell acute lymphoblastic leukemia. Leukemia 7:1204, 1993
42. McBride OW, Kirsh I. Hollis G, Nau M, Battey J, Minna J: Human L-myc (MYCL) proto-oncogene is on chromosome 1p32. Eighth International Workshop on Human Gene Mapping. Cytogenet Cell Genet 40:694, 1985
43. Bohmann D, Bos TJ, Admon A, Nishimura T, Vogt PK, Tjian R: Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science 238:1386, 1987
44. Cybulsky MI, Freis JWU, Williams AJ, Sultan P, Eddy R, Byers M, Shows T, Gimbrone MA, Collins T: Gene structure, chromosomal location, and basis for alternative mRNA splicing of the human VCAM1 gene. Proc Natl Acad Sci USA 88:7859, 1991
45. Offit K, Parsa NZ, Gaidano G, Filippa DA, Louie D, Pan D, Jhanwar SC, Dalla-Favera R, Chaganthi RS: 6q deletions define distinct clinico-pathologic subsets of non-Hodgkin's lymphoma. Blood 82:2157, 1993
46. Shapiro PE, Warburton D, Berger CL, Edelson RL: Clonal chromosomal abnormalities in cutaneous T-cell lymphoma. Cancer Genet Cytogenet 28:267, 1987
47. Sutherland GR, Baker E, Femandez KEW, Callen DF, Goodwin RG, Lupton S, Namen AE, Shannon MF, Vadas MA: The gene for human interleukin 7 (IL7) is at 8q12-13. Hum Genet 82:371, 1989
48. Sausville EA, Eddy JL, Makuch RW, Fishmann AB, Schechter GP, Matthews M, Glatstein E, Ihde DC, Kaye F, Veach SR, Phelps R, O'Connor T, Trepel JB, Cotelingam JD, Gazdar AF, Minna JD, Bunn PA: Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome: Definition of three distinctive prognostic groups. Ann Intern Med 109:372, 1988
49. Weinberg JM, Jaworsky C, Benoit BM, Telegan B, Rook AH, Lessin SR: The clonal nature of circulating Sézary cells. Blood 86:4257, 1995